| |
Group 1998(N=307) |
Group 2006(N=236) |
p |
| Male gender, % |
73.0 |
75.3 |
0.53 |
| Mean age ±SD, years |
39.1±9.8 |
41.0±10.7 |
0.03 |
| Drug users, % |
40.1 |
30.4 |
<0.001 |
| HCV/HBV coinfection, % |
38.6 |
41.0 |
0.87 |
| Mean CD4 T-cells, mm3 |
343 ± 314 |
244 ± 174 |
<0.001 |
| Baseline CD4 T-cells < 100, % |
17.3 |
20.8 |
0.30 |
| Baseline CD4 T-cells < 200, % |
33.6 |
40.7 |
0.09 |
| Baseline CD4 T-cells < 350, % |
55.7 |
80.5 |
<0.001 |
| Mean log10 HIV-RNA |
4.56 ± 0.97 |
4.91 ± 0.96 |
0.001 |
| Mean AIDS progression risk ±SD |
6.7 ± 9.6 |
10.2 ± 11.2 |
0.002 |
| Glycemia mg/dL (95% C.I.) |
90.4 (88.0-92.8) |
88.1 (85.0-91.2) |
0.27 |
| Triglycerides mg/dL (95% C.I.) |
159 (135-184) |
147 (135-159) |
0.34 |
| Cholesterol mg/dL (95% C.I.) |
168 (160-175) |
162 (156-168) |
0.28 |
|
